Increasing CD4/CD8 ratio confirmed after two years of long-acting cabotegravir and rilpivirine in the SCohoLART study.
Saved in:
| Title: | Increasing CD4/CD8 ratio confirmed after two years of long-acting cabotegravir and rilpivirine in the SCohoLART study. |
|---|---|
| Authors: | Loi, Gabriele1, loi.gabriele@hsr.it, Capra, Nicolò2, Lolatto, Riccardo2, Negri, Marcella1, Catalano, Gaia1, Passini, Flavia1, Moschetta, Nicolò1, Benelli, Claudia1, Nozza, Silvia1,2, Castagna, Antonella1,2, Muccini, Camilla2 |
| Source: | Frontiers in Virology; 2026, p1-7, 7p |
| Database: | Applied Science & Technology Source |
| ISSN: | 2673818X |
|---|---|
| DOI: | 10.3389/fviro.2026.1819287 |
